Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
NCT01502150 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 798
Last updated 2019-05-10
Summary
The goal of this research study is to collect information on the side effects of proton therapy and the details of proton treatment plans so that researchers can develop a method to predict the risk of side effects and to improve the planning and delivery of proton treatment for patients in the future.
Conditions
- Pediatric Cancer
Interventions
- OTHER
-
Data Collection
Information collected from follow-up visits post proton radiation therapy yearly or more often, and test results for at least 10-15 years.
- OTHER
-
Dose Distribution Data Collection
Data collection of complete plan information, including dose distribution, beam configuration and images, computed tomography (CT) images acquired on multiple days and 4D CT's for respiratory correlated imaging.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Arnold dela Cruz Paulino, MD · M.D. Anderson Cancer Center
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-16
- Primary Completion
- 2020-06-01
- Completion
- 2021-06-01
Countries
- United States
Study Locations
More Related Trials
-
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
NCT00016861 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma
NCT06620302 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours
NCT02303028 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fenretinide in Treating Children With Solid Tumors
NCT00003191 ·Status: COMPLETED ·Phase: PHASE1
-
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
NCT00020150 ·Status: COMPLETED ·Phase: PHASE1
-
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
NCT03750513 ·Status: RECRUITING ·Phase: PHASE1
-
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
NCT02446431 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study
NCT05372536 ·Status: COMPLETED ·Phase: NA
-
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
NCT00674193 ·Status: COMPLETED
-
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
NCT00083070 ·Status: COMPLETED ·Phase: PHASE1
-
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
NCT02095132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00025259 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine in Treating Children With Refractory Solid Tumors
NCT00005577 ·Status: COMPLETED ·Phase: PHASE1
-
Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment
NCT00458744 ·Status: WITHDRAWN ·Phase: PHASE1
-
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
NCT01294670 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
NCT00008424 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children
NCT02339350 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating Supportive Care for Children With Cancer: A Multi-Institutional Survey Study of Pediatric Oncology Patients and Parents
NCT01273194 ·Status: COMPLETED
-
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
NCT01962103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
NCT05004116 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 ·Status: COMPLETED
-
Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration
NCT00570817 ·Status: COMPLETED ·Phase: NA
-
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
NCT00502892 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
A Study of N9 Chemotherapy in Children With Neuroblastoma
NCT04947501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1